Moderna begins COVID vaccine trials among children under 12
Health
- 17 March, 2021
- 06:18
The US company Moderna has started a new phase of its coronavirus vaccine trials, Report informs with reference to Interfax.
At this stage, the drug’s effectiveness will be tested on children aged from six months to 12 years.
The first trial participants aged six months to 12 years have received a dose of the jab.
The company says that the clinical trials in this age group will be carried out among “healthy children in the US and Canada.”
During this stage, the specialists intend to “assess the safety, tolerability, reactogenicity, and efficacy of two doses of the mRNA-1273 vaccine, which are administered with 28 days interval.
Latest News
21:02
Iranian army launches drone attack on US base in Jordan
Other countries20:49
Another suspect detained over attempted attack on Armenia PM Pashinyan
Region20:32
Netanyahu orders expansion of security buffer zone in southern Lebanon
Other countries20:16
Bloomberg: The war with Iran may be ushering in a new nuclear age
Other countries19:51
Extreme weather in Afghanistan leaves 17 people dead, authorities say
Other countries19:27
Two unidentified drones crash in southeastern Finland in 'suspected territorial violation'
Other countries18:59
Ilham Aliyev awards Jamil Aliyev with Istiglal Order
Domestic policy18:44
Two more India-bound tankers pass Strait of Hormuz
Other countries18:19